Tiny study sheds light on rare male breast cancer
NCT ID NCT06133647
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at the medical records of 8 men diagnosed with breast cancer at Methodist Health System. Researchers wanted to understand their demographics, how their disease progressed, and what complications they faced. Because male breast cancer is very rare, this small review aims to gather more information to help guide future treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Research Institute at Methodist Health System
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Radiation may let breast cancer patients keep their nipple
- Which workout wins for breast cancer recovery? a trial puts cardio vs conditioning to the test
- Could a Post-Workout protein shake help breast cancer survivors rebuild muscle?
- Hidden heart risk: routine cancer scans could reveal cardiovascular danger in breast cancer survivors
- New PET tracer aims to spot hidden cancer spread in the abdomen